Jaguar Health Inc (JAGX)
0.2847
-0.01
(-4.43%)
USD |
NASDAQ |
May 08, 10:05
Jaguar Health Enterprise Value: 114.89M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 114.89M |
| May 06, 2024 | 120.38M |
| May 03, 2024 | 120.66M |
| May 02, 2024 | 113.54M |
| May 01, 2024 | 93.95M |
| April 30, 2024 | 90.99M |
| April 29, 2024 | 89.07M |
| April 26, 2024 | 81.03M |
| April 25, 2024 | 78.16M |
| April 24, 2024 | 78.13M |
| April 23, 2024 | 77.58M |
| April 22, 2024 | 81.00M |
| April 19, 2024 | 74.40M |
| April 18, 2024 | 80.20M |
| April 17, 2024 | 76.70M |
| April 16, 2024 | 80.55M |
| April 15, 2024 | 63.45M |
| April 12, 2024 | 55.27M |
| April 11, 2024 | 59.02M |
| April 10, 2024 | 61.37M |
| April 09, 2024 | 54.19M |
| April 08, 2024 | 51.98M |
| April 05, 2024 | 52.53M |
| April 04, 2024 | 50.71M |
| April 03, 2024 | 49.79M |
| Date | Value |
|---|---|
| April 02, 2024 | 49.77M |
| April 01, 2024 | 50.60M |
| March 28, 2024 | 50.16M |
| March 27, 2024 | 46.22M |
| March 26, 2024 | 45.32M |
| March 25, 2024 | 46.06M |
| March 22, 2024 | 45.99M |
| March 21, 2024 | 47.64M |
| March 20, 2024 | 47.84M |
| March 19, 2024 | 45.30M |
| March 18, 2024 | 44.83M |
| March 15, 2024 | 43.80M |
| March 14, 2024 | 44.85M |
| March 13, 2024 | 44.15M |
| March 12, 2024 | 43.45M |
| March 11, 2024 | 44.09M |
| March 08, 2024 | 46.18M |
| March 07, 2024 | 46.22M |
| March 06, 2024 | 47.85M |
| March 05, 2024 | 55.40M |
| March 04, 2024 | 58.89M |
| March 01, 2024 | 47.62M |
| February 29, 2024 | 33.66M |
| February 28, 2024 | 33.56M |
| February 27, 2024 | 33.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.95M
Minimum
Mar 12 2020
448.13M
Maximum
Jan 08 2021
66.58M
Average
37.72M
Median
Jan 27 2023
Enterprise Value Benchmarks
| BioSig Technologies Inc | 14.73M |
| BioVie Inc | 9.406M |
| First Wave BioPharma Inc | 2.248M |
| Genprex Inc | -2.000M |
| Adial Pharmaceuticals Inc | 3.377M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.17M |
| Revenue (Quarterly) | 2.30M |
| Total Expenses (Quarterly) | 9.486M |
| EPS Diluted (Quarterly) | -0.1249 |
| Gross Profit Margin (Quarterly) | 70.13% |
| Profit Margin (Quarterly) | -398.7% |
| Earnings Yield | -1.26K% |
| Normalized Earnings Yield | -1239.73 |